[Management of secondary hyperparathyroidism]

Clin Calcium. 2005 Sep:15 Suppl 1:217-24.
[Article in Japanese]
No abstract available

Publication types

  • Review

MeSH terms

  • Aniline Compounds / therapeutic use*
  • Calcinosis / etiology
  • Calcinosis / prevention & control
  • Calcium / blood
  • Cinacalcet
  • Clinical Trials as Topic
  • Drug Design
  • Drug Therapy, Combination
  • Humans
  • Hyperparathyroidism, Secondary / blood
  • Hyperparathyroidism, Secondary / drug therapy*
  • Hyperparathyroidism, Secondary / etiology
  • Kidney Failure, Chronic / complications
  • Naphthalenes / therapeutic use
  • Parathyroid Hormone / blood
  • Phenethylamines
  • Phosphorus / blood
  • Polyamines / therapeutic use*
  • Practice Guidelines as Topic
  • Propylamines
  • Receptors, Calcium-Sensing / agonists*
  • Sevelamer
  • Vascular Diseases / etiology
  • Vascular Diseases / prevention & control
  • Vitamin D / analogs & derivatives
  • Vitamin D / therapeutic use*

Substances

  • Aniline Compounds
  • N-(2-chlorophenylpropyl)-1-(3-methoxyphenyl)ethylamine
  • Naphthalenes
  • Parathyroid Hormone
  • Phenethylamines
  • Polyamines
  • Propylamines
  • Receptors, Calcium-Sensing
  • Vitamin D
  • Phosphorus
  • Sevelamer
  • Calcium
  • Cinacalcet